Featured Research

from universities, journals, and other organizations

Gastric banding associated with relatively poor long-term outcomes, study suggests

Date:
March 21, 2011
Source:
JAMA and Archives Journals
Summary:
In a study of 82 patients who were evaluated 12 or more years after undergoing laparoscopic adjustable gastric banding for morbid obesity, a majority of patients reported that they were satisfied with the procedure, although approximately 40 percent experienced major complications and nearly half required removal of their bands, according to a new study.

In a study of 82 patients who were evaluated 12 or more years after undergoing laparoscopic adjustable gastric banding for morbid obesity, a majority of patients reported that they were satisfied with the procedure, although approximately 40 percent experienced major complications and nearly half required removal of their bands, according to a report posted online that will appear in the July print issue of Archives of Surgery, one of the JAMA/Archives journals.

"There is substantial evidence that surgery is the only valid treatment for morbid obesity," the authors write as background information in the article. "Presently, the most commonly performed techniques are laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass, which is also typically performed laparoscopically." Opponents of LAGB claim it can result in mediocre quality of life and a significant number of complications, and that there is a tendency for patients to regain weight after some years.

Jacques Himpens, M.D., and colleagues at the European School of Laparoscopic Surgery, Saint Pierre University Hospital, Brussels, Belgium, conducted a clinical assessment of patients 12 or more years after undergoing LAGB to determine the long-term efficacy and safety of the surgery for morbid obesity. A total of 151 consecutive patients who were treated with LAGB between January 1, 1994 and December 31, 1997 were contacted at the end of 2009, and 82 (54.3 percent) were available for full evaluation.

"Based on a follow-up of 54.3 percent of patients, LAGB appears to result in a mean excess weight loss of 42.8 percent after 12 years or longer," the authors report.

Thirty-nine percent of patients experienced major complications, and 22 percent experienced minor complications. Nearly half the patients required removal of their gastric bands and nearly 60 percent needed additional operations.

"Still, 60.3 percent of the patients were satisfied, and the quality-of-life index was comparable to the nonsurgical average," the authors write.

Fourteen patients were switched to laparoscopic gastric bypass, with good results.

"The high failure rate of LAGB, at least in our hands, could be detrimental to its future continued widespread use as a restrictive weight loss operation," the authors conclude.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jacques Himpens; Guy-Bernard Cadiere; Michel Bazi; Michael Vouche; Benjamin Cadiere; Giovanni Dapri. Long-term Outcomes of Laparoscopic Adjustable Gastric Banding. Archives of Surgery, 2011; DOI: 10.1001/archsurg.2011.45

Cite This Page:

JAMA and Archives Journals. "Gastric banding associated with relatively poor long-term outcomes, study suggests." ScienceDaily. ScienceDaily, 21 March 2011. <www.sciencedaily.com/releases/2011/03/110321161906.htm>.
JAMA and Archives Journals. (2011, March 21). Gastric banding associated with relatively poor long-term outcomes, study suggests. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2011/03/110321161906.htm
JAMA and Archives Journals. "Gastric banding associated with relatively poor long-term outcomes, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/03/110321161906.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins